Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy and Safety of ANAkinra During Adult " COVID-19 " With Aggravating Respiratory Symptoms: a Multicenter Open-label Controlled Randomized Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04364009
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:51.688084+00:00
Published At
2021-01-15T00:00:00+00:00
Record Updated At
2021-01-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["COVID-19 Infection", "ANAKINRA Treatment", "Optimized Standard of Care (oSOC)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-01-15"
protocolSection.identificationModule.nctId
"NCT04364009"
protocolSection.identificationModule.officialTitle
"Efficacy and Safety of ANAkinra During Adult \" COVID-19 \" With Aggravating Respiratory Symptoms: a Multicenter Open-label Controlled Randomized Trial"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • COVID-19 Infection (protocolSection.conditionsModule.conditions)
  • ANAKINRA Treatment (protocolSection.conditionsModule.conditions)
  • Optimized Standard of Care (oSOC) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.